Gouvernance Harbin Gloria Pharmaceuticals Co., Ltd

002437

CNE100000QG8

Produits pharmaceutiques

Cours en clôture Shenzhen S.E. Autres places de cotation 30/07/2026			Varia. 5j.	Varia. 1 janv.
2,840 ^CNY	-1,39%		-1,05%	-7,49%

27/04	HARBIN GLORIA PHARMACEUTICALS Co., LTD publie ses résultats pour le premier trimestre clos le 31 mars 2026	CI
14/04	HARBIN GLORIA PHARMACEUTICALS Co., LTD publie ses résultats pour l'exercice clos le 31 décembre 2025	CI

Comité Exécutif: Harbin Gloria Pharmaceuticals Co., Ltd

Dirigeant

Fonctions occupéesDepuis

Lei Feng Guo

53 ans

Chief Executive Officer	26/12/2022
Director of Finance/CFO	15/01/2024

Yue Yin Liu

40 ans

Corporate Secretary

16/11/2020

Xue Long Bai

Investor Relations Contact

Composition du Conseil d'Administration: Harbin Gloria Pharmaceuticals Co., Ltd

Administrateur

ComitésDepuis

Zhen Yu Shen

47 ans

Chairman

06/02/2025

Lei Feng Guo

53 ans

Compensation Committee	11/11/2022
Nominating Committee	11/11/2022

Kang Zhou

42 ans

Audit Committee

11/11/2022

Yu Hong Xu

58 ans

Director/Board Member	14/01/2026
Independent Dir/Board Member	14/01/2026

Li Da Wang

52 ans

Director/Board Member	06/02/2025
Independent Dir/Board Member	06/02/2025

Yi Chen

51 ans

Director/Board Member	06/02/2025
Independent Dir/Board Member	06/02/2025

Yu Bing Song

50 ans

Director/Board Member

28/07/2023

Yue Yin Liu

40 ans

Director/Board Member

14/03/2025

Dernières Nominations: Harbin Gloria Pharmaceuticals Co., Ltd

15/01	Harbin Gloria Pharmaceuticals Co., Ltd approuve lélection de Xu Yuhong en tant qu'administrateur indépendant, effectif au 14 janvier 2026	CI
17/03/25	HARBIN GLORIA PHARMACEUTICALS Co, LTD élit Liu Yueyin en tant qu'administrateur non indépendant	CI
07/02/25	HARBIN GLORIA PHARMACEUTICALS Co, LTD annonce des nominations au sein de sa direction	CI
21/12/22	Harbin Gloria Pharmaceuticals Co., Ltd annonce des nominations à des postes de direction	CI
14/11/22	Harbin Gloria Pharmaceuticals Co., Ltd approuve les nominations de cadres supérieurs	CI

Plus d'Actualités

Anciens Dirigeants et Administrateurs: Harbin Gloria Pharmaceuticals Co., Ltd

Insider

Fonctions occupées

DepuisJusqu'au

Min Pan

Director/Board Member	20/12/2022	06/02/2025
Independent Dir/Board Member	20/12/2022	06/02/2025

Xiu Qiang Diao

Director/Board Member	09/09/2014	01/01/2025
Director of Finance/CFO	01/11/2012	18/12/2020
Corporate Officer/Principal	18/12/2020	01/01/2025

Li Na Wang

Director/Board Member

18/05/2020

23/08/2024

Feng Jiang

Director/Board Member

14/07/2023

10/05/2024

Ming Hui Jiang

Director/Board Member	20/12/2022	10/05/2024
Independent Dir/Board Member	20/12/2022	10/05/2024

Ran Wang

Corporate Officer/Principal

26/12/2022

18/04/2024

Jia Feng Zang

Chief Tech/Sci/R&D Officer

27/04/2021

15/01/2024

Xiao Dan Zhang

Director/Board Member	20/12/2022	-
Independent Dir/Board Member	20/12/2022	-

Bing Yuan Hao

Chairman

22/05/2020

11/11/2022

Ji Man Zhu

Director/Board Member	-	27/09/2022
Chairman	26/06/2008	-

Hui Xue

Director/Board Member	18/05/2020	27/09/2022
Independent Dir/Board Member	18/05/2020	27/09/2022

Zuo Zhe Ji

Director/Board Member	20/05/2021	-
Director of Finance/CFO	18/12/2020	-

Da Yong Zhang

Chief Executive Officer

27/04/2020

Xiao Dong Liu

Director/Board Member	-	16/03/2020
Independent Dir/Board Member	-	16/03/2020

Yu Wang

Director/Board Member	15/05/2019	-
Corporate Secretary	23/05/2019	-

Hong Bing Yang

Chief Executive Officer	01/09/2004	01/12/2017
Sales & Marketing	01/09/2004	01/12/2017

Jia Nong Mao

Corporate Officer/Principal

01/01/2015

01/12/2016

Qiang Lü

Chief Tech/Sci/R&D Officer

01/02/2015

01/05/2016

De Xin Sun

Chief Investment Officer

01/04/2012

01/02/2015

Hua Rong Yang

Director/Board Member	01/01/2009	09/09/2014
Director/Board Member	18/05/2020	20/12/2022
Independent Dir/Board Member	18/05/2020	20/12/2022

Li Li Zeng

Director/Board Member

13/12/2019

Chang Liu

Director/Board Member	01/01/2009	-
Corporate Secretary	01/01/2009	-

Zhong Qiu Zhao

Director/Board Member	01/06/2008	-
Independent Dir/Board Member	01/06/2008	-

Qi Dong

Director/Board Member	01/06/2008	-
Independent Dir/Board Member	01/06/2008	-

Gen Qiang Cheng

Director/Board Member

01/06/2008

Yun Dong Chang

Director/Board Member

22/03/2011

Li Qun He

Director/Board Member	01/01/2003	-
Chief Tech/Sci/R&D Officer	01/01/2003	-

Hong Bing Yang

Director/Board Member	-	-
Chief Executive Officer	-	-

Li Hui Bai

Chairman	-	-
Director/Board Member	22/07/2020	27/09/2022

Xiao Ge Xu

Director/Board Member	-	-
Independent Dir/Board Member	-	-

Xue Xiang

Corporate Officer/Principal

Yun Pei Guo

Director/Board Member	-	-
Independent Dir/Board Member	-	-

Wan Cheng Long

Chief Executive Officer

27/04/2020

Rui Hua Wang

Director/Board Member	-	-
Independent Dir/Board Member	-	-

Su Mei Zhang

Director/Board Member

Jun Ling Li

Director/Board Member

Jin Hu

Corporate Officer/Principal	-	-
Director/Board Member	22/07/2020	04/12/2022
Chairman	04/12/2022	-

Eric Mao

Corporate Officer/Principal

Dong Xu Wang

Director/Board Member	-	14/06/2020
Chief Executive Officer	-	-
Chairman	14/06/2020	-

Distribution de l'Âge des Dirigeants

Parité Homme Femme

Homme	5
Femme	4

Dont comité exécutif

Homme	2
Femme	1

Dont Administrateurs

Homme	4
Femme	4

HARBIN GLORIA PHARMACEUTICALS Co Ltd est une société basée en Chine dont l'activité principale consiste en la recherche, le développement, la production et la vente de produits pharmaceutiques. La société exerce ses activités à travers trois segments. Le segment de la médecine traditionnelle chinoise a pour produit principal les pilules et comprimés Annao. Les produits du segment des produits pharmaceutiques chimiques comprennent des médicaments cardiovasculaires et cérébrovasculaires, des médicaments musculo-squelettiques, des vitamines, des électrolytes, des analgésiques, des anti-infectieux, des médicaments antitumoraux et autres. Le segment « Autres » est dédié à la recherche et au développement pharmaceutiques, aux services cliniques et autres. La société distribue ses produits sur le marché national et à l'international.

Employés

2 350

Secteur

Produits pharmaceutiques

Agenda

27/08 Publication des résultats - Q2 2026

Plus d'informations sur la société